Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer’s disease mice-Reference-Cited by-同舟云学术

Interleukin-2 improves amyloid pathology, synaptic failure and memory in Alzheimer’s disease mice

Published:2016-12-20 Issue: Volume: Page:aww330
ISSN:0006-8950
Container-title:Brain
language:en
Short-container-title:Brain

Author:

Alves Sandro,Churlaud Guillaume,Audrain Mickael,Michaelsen-Preusse Kristin,Fol Romain,Souchet Benoit,Braudeau Jérôme,Korte Martin,Klatzmann David,Cartier Nathalie

Publisher

Oxford University Press (OUP)

Subject

Neurology (clinical)

Link

http://academic.oup.com/brain/article-pdf/140/3/826/18245155/aww330.pdf

Reference70 articles.

1. Interleukin-2 as a neurotrophic factor for supporting the survival of neurons cultured from various regions of fetal rat brain

2. Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes

3. Permeability of the mouse blood–brain barrier to murine interleukin-2: predominance of a saturable efflux system

4. Imaging the microanatomy of astrocyte-T-cell interactions in immune-mediated inflammation;Barcia;Front Cell Neurosci,2013

5. In vivo imaging reveals a phase-specific role of STAT3 during central and peripheral nervous system axon regeneration

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the role of astrogliosis in Alzheimer’s disease Pathology: Insights into mechanisms and therapeutic approaches;International Immunopharmacology;2024-11

2. Common cytokine receptor gamma chain family cytokines activate MAPK, PI3K, and JAK/STAT pathways in microglia to influence Alzheimer’s Disease;Frontiers in Molecular Neuroscience;2024-09-11

3. Alzheimer's disease approaches - Focusing on pathology, biomarkers and clinical trial candidates;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-08

4. Low‐Dose Interleukin‐2 Reverses Traumatic Brain Injury‐Induced Cognitive Deficit and Pain in a Murine Model;Annals of Neurology;2024-07-20

5. Low-dose interleukin-2 in patients with bipolar depression: a phase 2 randomised double-blind placebo-controlled trial;2024-07-19